<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>2025-05-04 Nature Digest</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
            line-height: 1.6;
            max-width: 800px;
            margin: 0 auto;
            padding: 20px;
            color: #333;
        }
        h1 {
            color: #2c3e50;
            border-bottom: 2px solid #eee;
            padding-bottom: 10px;
        }
        .paper {
            margin-bottom: 30px;
            padding: 20px;
            background: #f8f9fa;
            border-radius: 5px;
        }
        .paper h2 {
            margin-top: 0;
            color: #2c3e50;
        }
        .paper a {
            color: #3498db;
            text-decoration: none;
        }
        .paper a:hover {
            text-decoration: underline;
        }
        .doi {
            color: #666;
            font-size: 0.9em;
        }
        .summary {
            margin-top: 10px;
            color: #444;
        }
        .journal {
            color: #666;
            font-style: italic;
            margin-bottom: 10px;
        }
    </style>
</head>
<body>
    <h1>2025-05-04 Nature Digest</h1>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184964">Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study presents a novel nanoparticle-based, tumor-specific surface marker–independent targeting strategy (TRACER) that selectively labels tumors with azide groups to enhance the delivery and efficacy of immune-activating anti–4-1BB antibodies. This approach significantly improves therapeutic outcomes by increasing tumor immune cell infiltration and survival while reducing off-target liver toxicity, addressing a major limitation in cancer immunotherapy related to tumor marker scarcity and hepatotoxicity.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/179572">AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that AMPK is essential for regulatory T cells (Tregs) to adapt their mitochondrial metabolism and maintain full suppressive function in metabolically stressed environments such as tumors and viral pneumonia. By linking AMPK activity to DNA methylation-dependent regulation of mitochondrial function, these findings identify a critical mechanism underlying Treg metabolic adaptation with potential therapeutic implications in cancer and inflammatory tissue injury.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/179262">Long noncoding RNA BCYRN1 promotes cardioprotection by enhancing human and murine regulatory T cell dynamics</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">The study identifies the long noncoding RNA BCYRN1 in cardiosphere-derived cell extracellular vesicles as a key enhancer of regulatory T cell proliferation, migration, and IL-10 production through microRNA inhibition and autophagy pathways. This novel mechanism underlies BCYRN1's cardioprotective effects post-myocardial infarction, suggesting its therapeutic potential for boosting Treg activity in ischemic injury and other immune-related diseases.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/182709">CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell–mediated alloimmunity</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies a specific subset of CXCL12hi fibroblastic reticular cells in lymph nodes that regulate alloimmune responses by creating an immunosuppressive microenvironment through expression of key regulatory molecules and LTβR signaling. These CXCL12+ FRCs are critical for promoting heart allograft tolerance, and their manipulation offers a novel therapeutic strategy to enhance transplant acceptance.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184431">Inborn errors of immunity underlie clonal T cell expansions in large granular lymphocyte leukemia</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that clonal expansions of cytotoxic T lymphocytes in T cell large granular lymphocyte leukemia (T-LGLL) are frequently driven by underlying inborn errors of immunity (IEI), identified through rare deleterious genetic variants in immune-related genes. These findings uncover a novel link between cryptic immunodeficiency and persistent T cell proliferation, expanding the understanding of IEIs to include clonal hematopoiesis and bone marrow failure in T-LGLL.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188351">The complement system and kidney cancer: pathogenesis to clinical applications</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This review reveals that the complement system, traditionally viewed as an extracellular immune defense, also acts intracellularly to regulate tumor progression in kidney cancer by modulating the tumor microenvironment, cell signaling, and immune responses. By highlighting complement components as novel immunotherapeutic targets, it underscores the potential for complement inhibitors to be combined with existing treatments, offering new strategies to overcome kidney cancer’s treatment resistance and metastatic tendencies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188355">The multiverse of CD46 and oncologic interactions</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">CD46, beyond its traditional role in complement regulation, is now recognized as a multifunctional protein involved in immune modulation, pathogen entry, and notably, cancer progression through its elevated expression linked to malignancy and metastasis. This multifunctionality has spurred novel oncologic therapies targeting CD46, including viral vector-based treatments and antibody-drug conjugates, highlighting its potential as a versatile cancer treatment target.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00424-3?rss=yes">Hepcidin and fungal infections: The liver fights back</a></h2>
        <div class="journal">Cell Reports</div>
        <div class="doi">DOI: 10.placeholder-20250504001358</div>
        <div class="summary">Arekar et al. discovered that the liver-derived peptide hepcidin can therapeutically improve outcomes in invasive Candida albicans infections by reducing iron availability in the kidneys and protecting against renal damage. This finding highlights hepcidin agonists as a novel treatment strategy that targets iron metabolism to enhance host defense against fungal pathogens.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184095">Mycobacterium tuberculosis hijacks the UBE2O pathway to regulate host iron homeostasis</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">The study reveals that Mycobacterium tuberculosis manipulates the host’s UBE2O protein degradation pathway to control iron homeostasis within infected cells. This novel mechanism uncovers a critical bacterial strategy for securing essential nutrients, offering potential targets for therapeutic intervention against tuberculosis.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/192422">Biallelic OSM deficiency presents with juvenile myelodysplastic syndrome and response to treatment</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies biallelic OSM deficiency as a cause of juvenile myelodysplastic syndrome, linking a genetic defect in the oncostatin M pathway to early-onset hematopoietic dysfunction. These findings reveal a novel molecular mechanism underlying pediatric myelodysplasia and suggest potential targeted treatment strategies for affected patients.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/183607">Restoring mitochondrial function promotes hematopoietic reconstitution from cord blood following cryopreservation-related functional decline</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that cryopreservation impairs hematopoietic stem and progenitor cell (HSPC) function from umbilical cord blood by disrupting mitochondrial activity, leading to reduced hematopoietic reconstitution, which can be partially restored by sulforaphane treatment. These findings uncover a mechanistic basis for the decline in UCB transplant efficacy over time and propose a novel intervention to enhance the clinical utility of long-term cryopreserved UCB.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/183099">Proteostasis and metabolic dysfunction characterize a subset of storage-induced senescent erythrocytes targeted for posttransfusion clearance</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies a subset of storage-induced senescent erythrocytes (CFSEhi RBCs) characterized by metabolic depletion, irreversible protein oxidation, impaired proteostasis, and altered membrane properties that lead to their selective clearance posttransfusion. These findings elucidate the molecular and cellular mechanisms underlying storage-related RBC aging, offering novel insights critical for improving transfusion efficacy and RBC storage strategies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188353">Chronic kidney disease enhances alternative pathway activity: a new paradigm</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies that chronic kidney disease (CKD) enhances the activity of the alternative complement pathway by altering its protein balance, thereby promoting systemic and vascular inflammation. This novel insight underscores the alternative pathway as a potential therapeutic target to mitigate inflammation-driven cardiovascular and kidney disease progression in CKD patients.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/186673">TET2 suppresses vascular calcification by forming an inhibitory complex with HDAC1/2 and SNIP1 independent of demethylation</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that TET2 suppresses vascular calcification by forming an inhibitory complex with HDAC1/2 and SNIP1, independently of its DNA demethylation activity, to repress RUNX2 transcription in vascular smooth muscle cells. This novel mechanism positions TET2 as a potential therapeutic target for preventing vascular calcification, especially in chronic kidney disease contexts.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/190850">Unveiling mechanisms underlying kidney function changes during sex hormone therapy</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study demonstrates that feminizing hormone therapy with estradiol improves measured kidney function and reduces tubular injury biomarkers, whereas masculinizing therapy with testosterone has neutral or adverse effects on kidney biomarkers and inflammation. These findings reveal sex hormones as key modulators of kidney physiology, providing insight into sex-specific differences in chronic kidney disease progression and highlighting potential for targeted precision medicine strategies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/191907">The differential effects of sex hormone therapy on kidney function: insights into biological sex differences</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study demonstrates that estrogen therapy appears to protect kidney function, while testosterone therapy may have detrimental effects on renal physiology in transgender individuals. These findings reveal important biological sex differences in kidney health and underscore the need to consider both endogenous and exogenous sex hormones in understanding and managing chronic kidney disease.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188743">Differential aortic aneurysm formation provoked by chemogenetic oxidative stress</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">The study demonstrates that chemogenetically induced endothelial oxidative stress selectively triggers abdominal aortic aneurysms via a DUSP3-mediated dephosphorylation of JNK1 and activation of KLF4-dependent pathways. This reveals regional vascular differences in redox signaling underlying aneurysm development and identifies DUSP3 as a promising therapeutic target for aortic aneurysm treatment.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/187063">Activin A activation of Smad3 mitigates innate inflammation in mouse models of psoriasis and sepsis</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study discovered that activin A triggers phosphorylation of Smad3 independently of TGF-β in macrophages responding to infectious stimuli, thereby regulating mitochondrial ATP metabolism to suppress innate inflammation. This novel activin A–Smad3 signaling axis serves as a crucial anti-inflammatory mechanism, with its disruption exacerbating sepsis and psoriasis in mouse models.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/173354">Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that collagen type VI deficiency in skeletal muscle disrupts the extracellular matrix's ability to regulate TGF-β bioavailability, leading to early dysregulation of the TGF-β pathway in a mouse model of collagen VI-related muscular dystrophies. This novel mechanistic link between ECM composition and TGF-β signaling offers new therapeutic targets to address muscle dysfunction in these disorders.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184659">IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies IL-33 as a crucial factor that promotes anti-TcdB antibody production through ST2+ ILC2-mediated enhancement of germinal center T follicular helper cells, thereby protecting against recurrent Clostridioides difficile infection in a mouse model. These findings reveal IL-33’s essential role in restoring humoral immunity and suggest it as a potential therapeutic target to prevent CDI recurrence.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/187711">Macrophage-mediated IL-6 signaling drives ryanodine receptor–2 calcium leak in postoperative atrial fibrillation</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study identifies infiltrating CCR2+ macrophage-derived IL-6 signaling as a critical driver of postoperative atrial fibrillation (poAF) via the STAT3-CaMKII pathway that induces ryanodine receptor–2 calcium leak in atrial cardiomyocytes. These findings reveal a novel inflammatory mechanism underlying poAF and suggest targeting macrophage-mediated IL-6/STAT3 signaling as a promising therapeutic approach to prevent arrhythmias after cardiac surgery.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/192414">GLP-1 receptor agonists for the treatment of alcohol use disorder</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">GLP-1 receptor agonists (GLP-1RAs) were found to reduce alcohol consumption in humans and preclinical models, whereas dipeptidyl peptidase-4 inhibitors (DPP-4Is) showed no such effect. This discovery highlights the potential of GLP-1RAs as a novel pharmacotherapy for alcohol use disorder, offering a new avenue for early harm reduction.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188314">Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), but not dipeptidyl peptidase-4 inhibitors (DPP-4Is), significantly reduce alcohol intake in both humans and animal models. These results highlight the potential of GLP-1RAs as a novel and effective treatment option for alcohol use disorder.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188533">Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study found that HIV persists in both naive and memory CD4+ T cells in children on long-term antiretroviral therapy, with distinct infected cell clones and unique HIV integration sites in each subset. This reveals that infected memory T cell clones in perinatally infected children rarely arise from naive cell differentiation, highlighting divergent viral reservoirs that may impact treatment strategies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188352">Complement’s involvement in allergic Th2 immunity: a cross-barrier perspective</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study reveals that the complement system, especially components C3 and C5, plays a crucial role in driving Th2-polarized allergic responses across multiple barrier sites including skin, gut, and respiratory tract. These findings underscore the complement system as a unifying mechanistic player in diverse Th2 allergic diseases, offering new avenues for targeted therapeutic strategies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00443-7?rss=yes">ER-PM tether Syt1 limits cell-to-cell connectivity via plasmodesmata during innate immune responses in Arabidopsis</a></h2>
        <div class="journal">Cell Reports</div>
        <div class="doi">DOI: 10.placeholder-20250504001358</div>
        <div class="summary">Li et al. discovered that the ER-PM tether protein Syt1 regulates plasmodesmata (PD) closure during innate immune responses by sensing PI(4,5)P2 levels and interacting with ANN4 to trigger PD-localized calcium signaling and callose deposition. This finding reveals a novel mechanism by which plants limit intercellular connectivity to restrict pathogen spread, enhancing understanding of cell-to-cell communication control during immune activation.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/193824">Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">The study reveals that crystal deposition induces tubule dilation, which in turn accelerates cyst formation in polycystic kidney disease. This finding uncovers a novel pathological mechanism linking crystal accumulation to cystogenesis, offering potential new targets for therapeutic intervention.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/174233">Weight loss in MASLD restores the balance of liver fatty acid sources</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504001359</div>
        <div class="summary">This study discovered that weight loss in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) significantly reduces intrahepatic triacylglycerol by markedly decreasing hepatic lipogenesis, while contributions from free fatty acids and dietary fat remain unchanged. This finding highlights hepatic lipogenesis as a central driver of MASLD pathology and a critical target for therapeutic interventions.</div>
    </div>
    
</body>
</html>